文献速递临床免疫临床生化

尿液硫氧还蛋白快速化学发光酶免疫分析的分析与临床验证

Analytical and clinical validation of rapid chemiluminescence enzyme immunoassay for urinary thioredoxin, an oxidative stress-dependent early biomarker of acute kidney injury.
PubMed 文献 · Clin Chim Acta · 2020-04-26

该研究开发了用于检测尿液硫氧还蛋白1的快速化学发光酶免疫分析法,并完成分析与临床验证。分析评价显示溶血血红蛋白导致测量值异常升高,pH<6.0的酸性尿导致硫氧还蛋白1浓度显著低估,但缓冲液调节pH可完全逆转。尿液硫氧还蛋白1在AKI患者中升高,且不受肾外氧化应激疾病或慢性肾脏病影响。

要点

  • 化学发光酶免疫分析法可在最短6分钟内完成尿液硫氧还蛋白1检测,而常规ELISA需超过4小时。
  • 溶血血红蛋白可导致测量值异常升高至可检测范围以上,但含红细胞的尿沉渣不影响测量。
  • pH<6.0的酸性尿导致硫氧还蛋白1显著低估,使用pH调节缓冲液可完全逆转该影响。

核心结论

  • 尿液硫氧还蛋白1的化学发光酶免疫分析系统可实现与氧化应激相关的AKI的快速、特异性诊断。

研究设计与样本

  • 开发了尿液硫氧还蛋白1的快速化学发光酶免疫分析法,并进行分析与临床验证。

主要发现

  • 分析评价显示溶血血红蛋白导致测量值异常升高,超出可检测范围。
  • 含红细胞的尿沉渣不影响测量。
  • 该法检测可在最短6分钟内完成,而常规ELISA需超过4小时。
  • pH<6.0的酸性尿导致硫氧还蛋白1浓度显著低估,使用pH调节缓冲液可完全逆转。
  • 尿液硫氧还蛋白1在AKI患者中升高,但不受低氧血症、心肌梗死等肾外氧化应激疾病或血清肌酐相当的慢性肾脏病影响。

临床怎么用

  • 该快速化学发光酶免疫分析法可用于尿液硫氧还蛋白1的检测,辅助AKI与氧化应激相关的特异性诊断。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Oxidative stress is now recognized to be an important therapeutic target in kidney diseases. However, there are currently no biomarkers that can be used clinically to diagnose renal oxidative stress. METHODS: A rapid assay system for urinary thioredoxin 1, an oxidative stress-dependent biomarker of acute kidney injury (AKI), was developed as a chemiluminescence enzyme immunoassay and validated analytically and clinically. RESULTS: Analytic evaluation revealed that hemolytic hemoglobin caused measurements to be abnormally high, above the detectable range. However, urine sediment containing red blood cells did not affect the measurements. Assays using our proposed chemiluminescence enzyme immunoassay were completed within as little as 6 min, whereas a conventional ELISA > 4 h. Aciduria <pH 6.0 led to a significant underestimation of thioredoxin 1 concentrations. However, the effects of aciduria were completely reversible with use of a buffer developed for pH adjustment. Urinary thioredoxin 1 was increased in patients with AKI, but was unaffected by extrarenal oxidative stress diseases, including hypoxemia and myocardial infarction, or by chronic kidney disease in which serum creatinine concentrations were comparable. CONCLUSIONS: These results suggest that the chemiluminescent enzyme immunoassay system for urinary thioredoxin 1 enables rapid and specific diagnosis of AKI associated with oxidative stress.

来源:Clin Chim Acta,查看原文。版权归原作者所有。

引用

  1. Yokoi S, Kasuno K, Nishimori K, et al. Analytical and clinical validation of rapid chemiluminescence enzyme immunoassay for urinary thioredoxin, an oxidative stress-dependent early biomarker of acute kidney injury. Clin Chim Acta. 2020. PMID: 32348784. doi:10.1016/j.cca.2020.04.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。